Extracapsular spread in oral squamous cell carcinoma

Head and Neck

Volumn 32, Issue 6, 2010, Pages 714-722

  Shaw, Richard J ^a,b   Lowe, Derek ^a   Woolgar, Julia A ^c   Brown, James S ^a   Vaughan, E David ^a   Evans, Christopher ^a   Lewis Jones, Huw ^a   Hanlon, Rebecca ^a   Hall, Gillian L ^c,e   Rogers, Simon N ^a,d  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c LIVERPOOL UNIVERSITY DENTAL HOSPITAL   (United Kingdom)

^d EDGE HILL UNIVERSITY   (United Kingdom)

^e Central Manchester Teaching Hospital   (United Kingdom)

Author keywords

Extracapsular spread; Oral squamous cell carcinoma; Prognosis; Survival

Indexed keywords

ADULT; AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CERVICAL LYMPH NODE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMMUNOSURVEILLANCE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PREDICTION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SMOKING; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK FACTORS;

EID: 77952748879     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21244     Document Type: Article

References (35)

1. Conway DI, Stockton DL, Warnakulasuriya KA, Ogden G, Macpherson LM. Incidence of oral and oropharyngeal cancer in United Kingdom (1990-1999): recent trends and regional variation. Oral Oncol 2006;42:586-592.
2. O'Dowd A. Skin cancer is on the increase but incidence of lung cancer is falling. BMJ 2007;335:322.
3. Cancer Research UK. Trends in UK cancer incidence. London, UK; 2007.
4. Conway DI, Brewster DH, McKinney PA, Stark J, McMahon AD, Macpherson LM. Widening socio-economic inequalities in oral cancer incidence in Scotland, 1976-2002. Br J Cancer 2007;96:818-820.
5. Nair U, Bartsch H, Nair J. Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis 2004;19:251-262.
6. Larson DL, Lindberg RD, Lane E, Goepfert H. Major complications of radiotherapy in cancer of the oral cavity and oropharynx. A 10-year retrospective study. Am J Surg 1983;146:531-536. (Pubitemid 13012484)
7. Rogers SN, Brown JS, Woolgar JA, et al. Survival following primary surgery for oral cancer. Oral Oncol 2008;45:201-211.
8. Carter RL, Barr LC, O'Brien CJ, Soo KC, Shaw HJ. Transcapsular spread of metastatic squamous cell carcinoma from cervical lymph nodes. Am J Surg 1985;150:495-499.
9. Greenberg JS, Fowler R, Gomez J, et al. Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer 2003;97:1464-1470. (Pubitemid 36297776)
10. Greenberg JS, El Naggar AK, Mo V, Roberts D, Myers JN. Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma. Implication for therapeutic decision making. Cancer 2003;98:508-515.
11. Johnson JT, Barnes EL, Myers EN, Schramm VL Jr, Borochovitz D, Sigler BA. The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol 1981;107:725-729.
12. Moor JW, Jose J, Johnston C, Coatesworth AP, MacLennan KA. Upper aerodigestive tract squamous cell carcinoma: distribution of extracapsular spread and soft tissue deposits in the neck. Acta Otolaryngol 2004;124:97-101.
13. Shah JP, Cendon RA, Farr HW, Strong EW. Carcinoma of the oral cavity. Factors affecting treatment failure at the primary site and neck. Am J Surg 1976;132:504-507.
14. Woolgar JA, Rogers SN, Lowe D, Brown JS, Vaughan ED. Cervical lymph node metastasis in oral cancer: the importance of even microscopic extracapsular spread. Oral Oncol 2003;39:130-137.
15. Wolf GT, Urba S, Hazuka M. Induction chemotherapy for organ preservation in advanced squamous cell carcinoma of the oral cavity and oropharynx. Recent Results Cancer Res 1994;134:133-143.
16. Spaulding MB, Fischer SG, Wolf GT. Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. The Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group. J Clin Oncol 1994;12:1592-1599.
17. Rogers SN, Beirne JC, Patel M, Vaughan ED, Brown JS. A clinician friendly computerised head and neck oncology audit: the first year results. Ann R Coll Surg Engl 1996;78(Suppl 1):14-18.
18. Hall GL, Kademani D, Risk JM, Shaw RJ. Tissue banking in head and neck cancer. Oral Oncol 2008;44:109-115.
19. Alvi A, Johnson JT. Extracapsular spread in the clinically negative neck (N0): implications and outcome. Otolaryngol Head Neck Surg 1996;114:65-70.
20. Sutton DN, Brown JS, Rogers SN, Vaughan ED, Woolgar JA. The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2003;32:30-34. (Pubitemid 36284849)
21. Woolgar JA, Triantafyllou A. Pitfalls and procedures in the histopathological diagnosis of oral and oropharyngeal squamous cell carcinoma and a review of the role of pathology in prognosis. Oral Oncol 2009;45:361-385.
22. Shaw RJ, McGlashan G, Woolgar JA, et al. Prognostic importance of site in squamous cell carcinoma of the buccal mucosa. Br J Oral Maxillofac Surg 2009;47:356-359.
23. Woolgar JA, Triantafyllou A. Neck dissections: a practical guide for the reporting histopathologist. Curr Diag Pathol 2007;13:499-511. (Pubitemid 350061159)
24. Woolgar JA, Triantafyllou A. Lymph node metastases in head and neck malignancies: Assessment in practice and prognostic importance. Diagnostic Histopathology (in press).
25. Kumar B, Cordell KG, Lee JS, et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008;26:3128-3137.
26. Worden FP, Kumar B, Lee JS, et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol 2008;26:3138-3146.
27. Anneroth G, Hansen LS, Silverman S Jr. Malignancy grading in oral squamous cell carcinoma. I. Squamous cell carcinoma of the tongue and floor of mouth: histologic grading in the clinical evaluation. J Oral Pathol 1986;15:162-168.
28. Shaw RJ, Hall GL, Lowe D, et al. CpG island methylation phenotype (CIMP) in oral cancer: associated with a marked inflammatory response and less aggressive tumour biology. Oral Oncol 2007;43:878-886. (Pubitemid 47369250)
29. Burnet FM. The concept of immunological surveillance. Prog Exp Tumor Res 1970;13:1-27.
30. Birkeland SA, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 1995;60:183-189.
31. Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 2000;356:1795-1799.
32. Tan SY, Fan Y, Luo HS, Shen ZX, Guo Y, Zhao LJ. Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer. World J Gastroenterol 2005;11:1210-1214. (Pubitemid 40353010)
33. Vora AR, Rodgers S, Parker AJ, Start R, Rees RC, Murray AK. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma. Br J Cancer 1997;76:836-844. (Pubitemid 27401932)
34. Paik S. Development and clinical utility of a 21-gene recurrence score prognostic assay in patients with early breast cancer treated with tamoxifen. Oncologist 2007;12:631-635.
35. Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 2005;27:843-850.